Format

Send to

Choose Destination
Clin Neurophysiol. 2007 Feb;118(2):301-7. Epub 2006 Nov 30.

Transcallosal inhibition in amyotrophic lateral sclerosis.

Author information

1
Laboratory of Human Cortical Physiology, Department of Neurology, University of Rostock, Germany. matthias.wittstock@med.uni-rostock.de

Abstract

OBJECTIVE:

Assessment of upper motor neuron (UMN) involvement is essential for the diagnosis of amyotrophic lateral sclerosis (ALS). In a number of ALS cases, mirror movements (MM) suggest an involvement of transcallosal fibre tracts in conjunction with UMN involvement. The present study analysed whether deficient transcallosal inhibition (TI) tested by TMS enables detection of cortical affection in ALS, even at early stages of the disease.

METHODS:

In three patients with definite ALS and 12 patients with early ALS (aged 64.1+/-7.8 years) TMS investigation included analysis of contralateral (cMEP) and ipsilateral (iMEP) motor evoked potentials as well as measurement of TI (latency, duration) with recording from both first dorsal interosseus muscles.

RESULTS:

Clinical UMN signs were present in four patients. 83.3% of patients showed a pathological TI (prolongation or loss of TI). Five out of eight ALS patients showing a pathological TI had no clinical UMN signs. Two of these patients showed MM. One patient displayed also pathological findings in TI investigation.

CONCLUSIONS:

Our findings suggest a functional deficit of transcallosal fibre tracts even at early stages of the disease still lacking clinical UMN signs.

SIGNIFICANCE:

Measurement of TI tested by TMS can detect an involvement of the cortical output system in ALS and may be helpful in an early assessment of the diagnosis.

PMID:
17140846
DOI:
10.1016/j.clinph.2006.09.026
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center